Key indicators: single-crystal X-ray study; T = 90 K; mean (C-C) = 0.002 Å; R factor = 0.028; wR factor = 0.066; data-to-parameter ratio = 14.6.
The crystal structure of the title compound {systematic name: (S)-(+)-N-[1-(2-chlorophenyl)-2-oxocyclohexyl]methanaminium chloride}, C 13 H 17 ClNO + ÁCl À , was determined at 90 (2) K. The (S)-(+)-ketamine hydrochloride salt is a well known anesthetic compound and is dramatically more potent than its R isomer. In the title compound, the cyclohexanone ring adopts a chair conformation with the oxo group in the equatorial orientation. The methylamino and 2-chlorophenyl groups at the 2-position have an equatorial and an axial orientation, respectively. The packing of ions is stabilized by an infinite one-dimensional Á Á ÁClÁ Á ÁH-N-HÁ Á ÁClÁ Á Á hydrogen-bonding network, involving NH 2 + groups as donors and chloride anions as acceptors. 
Related literature

Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
Comment
The title compound, (S)-(+)-ketamine hydrochloride, has been investigated by single-crystal X-ray diffraction at 90 (2) K ( Fig. 1 and 2 ). The use of ketamine has been shown to lead to a state of dissociative anesthesia (Domino et al., 1965) . This study focuses on the S isomer of the well known anesthetic compound ketamine hydrochloride because it is dramatically more potent than its R isomer (White et al., 1985) . The pure S isomer is available commercially as Ketanest S TM , while the racemic mixture, containing both S and R isomers is available under many names, including: Ketalar et al., 1995) . In comparison to the racemic mixture, the S-isomer produces analgesic and anesthetic effects with twice the potency of the racemic (White et al., 1985) . Increased potency enables the use of a much lower dosage while still producing the required effect, in turn leading to a quicker recovery time from the anesthesia (Pees et al., 2003) . The potential advantages of the S isomer over the racemic mixture have lead to an increase in clinical use of the enantiomerically pure compound, particularly in Europe (Marhofer et al., 2001) . The potency, the increasing clinical usage, and the strong potential for abuse of (S)-(+)-Ketamine hydrochloride, provide a need for the complete characterization of this molecule, and its previously unpublished crystal structure. An unequivocal understanding of the solid-state crystal structure of the compound is a necessity for detection and identification methods such as THz vibrational spectroscopy, or solid-state NMR, among others. This study has determined that the compound crystallizes in the monoclinic space group P2 1 , with a unit cell volume of 662.56 (6) Å 3 at 90 K, and Z value 2. The complete atomic coordinates have also been determined.
Experimental
All material used for this work was purchased from Sigma-Aldrich (minimum 99% pure) and used without further purification. The absolute configuration of the enantiomer was verified by measuring the optical rotation of the material using a Jasco DIP-1000 digital polarimeter. The absolute configuration determined from anomalous dispersion-effects is consistent with the expected enantiomer. Figures Fig. 1 . Perspective view of the title salt, with the atom numbering scheme and thermal ellipsoids drawn at 50% probability level. H atoms have been omitted for clarity 
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